Expertise

It's at the heart of everything we do

e.g. asthma, appendicitis, Wright, Peter Kroll

EvidenceCare offers healthcare providers complete access to content curated by some of the industry’s foremost experts. We continue to develop content to meet the needs of our customers.

Acute Coronary Syndrome (ACS)

William Brady, MD

Acute Coronary Syndrome (ACS)

CME: Up to 8 Launch Protocol
The EvidenceCare Acute Coronary Syndrome (ACS) pathway is based off of the 2013 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) STEMI guidelines, 2014 American College of Cardiology/American Heart Association (ACC/AHA) NSTEMI guidelines and includes the 2015 American Heart Association (AHA) Acute Coronary Syndromes update. All phases of ACS care are addressed, with focus on appropriate intervention strategies for NSTEMI and STEMI care, including care of patients after resuscitated cardiac arrest with suspected ACS. Included are the 2015 updates on STEMI care that reflect guideline changes based on the interval of time of symptom onset to intervention versus previous recommendations based on interval from first medical contact to intervention.
Read More

Acute Diarrheal Infections

Mark Riddle, MD

Acute Diarrheal Infections

Acute diarrheal infections are a common health problem globally and among both individuals in the United States and traveling to developing world countries. Multiple modalities including antibiotic and non-antibiotic therapies have been used to address these common infections. Information on treatment, prevention, diagnostics, and the consequences of acute diarrhea infection has emerged and helps to inform clinical management. In this ACG Clinical Guideline, the authors present an evidence-based approach to diagnosis, prevention, and treatment of acute diarrhea infection in both US-based and travel settings. This EvidenceCare Protocol is based on the American College of Gastroenterology 2016 publication "ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults".
Read More

Advanced Cardiac Life Support (ACLS)

CME: Up to 2 Launch Protocol
The EvidenceCare Advanced Cardiac Life Support pathway is based off the 2015 American Heart Association (AHA) guidelines. This offers providers a structured approach to managing fatal arrhythmias and adult resuscitation. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests.
Read More

Anorectal Disorders

William Whitehead, PhD

Anorectal Disorders

These guidelines summarize the definitions, diagnostic criteria, differential diagnoses, and treatments of a group of benign disorders of anorectal function and/or structure. Disorders of function include defecation disorders, fecal incontinence, and proctalgia syndromes, whereas disorders of structure include anal fissure and hemorrhoids. Each section reviews the definitions, epidemiology and/or pathophysiology, diagnostic assessment, and treatment recommendations of each entity. This EvidenceCare Protocol is based on the American College of Gastroenterology 2014 publication "ACG Clinical Guideline: Management of Benign Anorectal Disorders".
Read More

Antibiotic Advisor

Our Antibiotic Guide is a comprehensive resource for providers to access antimicrobial treatment regimens on nearly every infectious condition. Whether your patient has sepsis, Hospital-Acquired Pneumonia (HAP), or is a child with meningitis, we have you covered. Furthermore, we allow you to customize the treatment regimen based on variables (such as weight and drug allergies) that are specific to your patient.
Read More

Asthma

CME: Up to 4 Launch Protocol
The EvidenceCare Asthma pathway allows providers to utilize a structured approach to the management of pediatric and adult patients with Asthma. Topics that are covered include acute exacerbations and impending respiratory arrest. The Pediatric Asthma Score (PAS) and the Pediatric Respiratory Asthma Measurement (PRAM) are embedded as decision rules to help the provider risk stratify their patient. Guidelines recommendations are included from the Managing Asthma Exacerbations in the Emergency Department Summary of the National Asthma Education and Prevention Program Expert Panel (ATS 2009), British Guidelines on the Management of Asthma (2014), and multiple Cochrane Database Systematic Reviews.
Read More

C. diff (Pseudomembranous Colitis)

Christina Surawicz, MD, MACG

C. diff (Pseudomembranous Colitis)

CME: Up to 2 Launch Protocol
Clostridium difficile infections (CDI) continue to be a great burden in the United States. In 2015, the CDC estimated there were close to 500,000 cases and 29,000 deaths within 30 days of diagnosis. The EvidenceCare C. diff pathway assists providers with appropriate prevention strategies, diagnosis, and treatment of CDI. A treatment algorithm is included based on your patient's severity of disease and number of recurrences. Optimal antibiotic selection for each subtype of CDI is included. There is a discussion on the evidence related to probiotic and fecal microbiota transplant (FMT) use to prevent recurrence of CDI. Evidence is included from the American College of Gastroenterology's (ACG) 2013 Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections as well as…
Read More

Chest Pain: Rule-out ACS

Amal Mattu, MD

Chest Pain

CME: Up to 2 Launch Protocol
Chest pain is the second most common presentation in the emergency department with an estimated 5 million patients presenting annually. A large percentage of these patients are at a Low Risk for acute coronary syndrome and can be safely managed on an Outpatient basis. The EvidenceCare Low Risk Chest Pain pathway helps providers risk stratify their patient who present with chest pain that the provider does not have suspicion for Acute Coronary Syndrome (ACS). The strengths and limitations of 5 risk stratification tools (the HEART Score, HEARTS3, EDACS-ADP, and ADAPT-ADP) are reviewed. Each of these tools have been validated and have the ability to identify patients at Low Risk for Major Adverse Cardiac Event (MACE) within the next 30 days.…
Read More

Chronic Obstructive Pulmonary Disease (COPD)

CME: Up to 4 Launch Protocol
Chronic obstructive pulmonary disease, or COPD, is the 4th leading cause of death in the world. The EvidenceCare Chronic Obstructive Pulmonary Disease (COPD) protocol provides recommendations for the diagnostic work-up, optimal therapeutic management and disposition of an acute exacerbation of COPD based on severity and response to initial treatment. Recommendations are based on the latest research and guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the American Thoracic Society, the National Institute for Health and Care Excellence (NICE), and the Veteran’s Health Administration and Department of Defense (VA/DoD).
Read More

CLABSI (Central Line-Associated Bloodstream Infection)

Stephen Liang, MD

CLABSI (Central line associated blood stream infections)

CME: Up to 2 Launch Protocol
Central line associated blood stream infections (CLABSI) are among the most frequent health care-associated infections today, with around 250,000 cases per year. CLABSIs cause substantial morbidity and mortality as well as increased costs to the health care system including prolonged hospital stays. A recent CDC report estimated the cost of each CLABSI event at $16,550. While CLABSIs are serious infections, they are often preventable when evidence-based guidelines are followed. The EvidenceCare CLABSI Prevention Protocol incorporates recommendations from the Infection Disease Society of America (IDSA), The Society for Healthcare Epidemiology of America (SHEA), and the Centers for Disease Control (CDC). These recommendations provide guidelines for the insertion of venous catheters, criteria for maintaining the catheter, and implementation of prompt discontinuation strategies.
Read More

Concussion

CME: Up to 3 Launch Protocol
Concussions present many challenges to providers including initial assessment of severity of injury, management of acute and prolonged concussive symptoms and evaluation of patients for readiness to return to activities. The EvidenceCare Concussion pathway provides recommendations for the immediate evaluation of mild traumatic brain injury and includes decision tools to assess the need for neuro-imaging. Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians, Centers for Disease Control (CDC), Veterans Health Administration and Department of Defense (VA/DoD), Ontario Neurotrauma Foundation (ONF) and Consensus Statement from the 4th International Conference on Concussion in Sport.
Read More

Congestive Heart Failure (CHF)

Semhar Tewelde, MD

Congestive Heart Failure (CHF)

CME: Up to 4 Launch Protocol
In the United States alone approximately 6 million suffer from heart failure (HF). The EvidenceCare Congestive Heart Failure pathway provides recommendations on the diagnostic work-up, optimal therapeutic management, and disposition of the acutely decompensated heart failure based on their severity of disease and volume status. This pathway also includes a risk stratification tool to assist providers in disposition decisions of patients who are mildly decompensated and may be candidates for treatment at home. The Congestive Heart Failure pathway is based on the 2013 ACCF/AHA Guideline for Management of Heart failure, 2012 European Society of Cardiology guidelines for Acute and Chronic Heart Failure, the 2010 Heart Failure Society of America Comprehensive Practice Guideline, and 2009 Society of Chest Pain Centers recommendations.
Read More

Diabetic Emergencies

Kelly Williamson, MD

Diabetic Emergencies

The EvidenceCare Diabetic Emergencies pathway provides treatment guidelines for the most common and immediately life-threatening diabetes complications: hyperglycemia, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. The pathway also provides treatment recommendations for pediatric patients with hypoglycemia and diabetic ketoacidosis. The recommendations are based on the latest research from American Diabetes Association, Diabetes Care, and Diabetologia.
Read More
These guidelines for the workup an management of dyspepsia were developed jointly by the American College of Gastroenterology (ACG) and the Canadian Association of Gastroenterology (CAG). They suggest that patients ≥60 years of age presenting with dyspepsia are investigated with upper gastrointestinal endoscopy to exclude organic pathology. This is a conditional recommendation and patients at higher risk of malignancy (such as spending their childhood in a high risk gastric cancer country or having a positive family history) could be offered an endoscopy at a younger age. Alarm features should not automatically precipitate endoscopy in younger patients but this should be considered on a case-by-case basis. It is also recommended that patients <60 years of age have a non-invasive test for…
Read More

Gastroesophageal Reflux Disease (GERD)

Philip Katz, MD

Gastroesophageal reflux disease (GERD)

Gastroesophageal reflux disease (GERD) is arguably the most common disease encountered by the gastroenterologist. It is equally likely that the primary care providers will find that complaints related to reflux disease constitute a large proportion of their practice. The following guideline provides an overview of GERD and its presentation, and recommendations for the approach to diagnosis and management of this common and important disease. The guideline will review the presentations of any risk factors for GERD, the diagnostic modalities and their recommendation for use and recommendations for medical, surgical and endoscopic management including comparative effectiveness of different treatments. Extraesophageal symptoms and complications will be addressed as will the evaluation and management of “refractory” GERD. The document will conclude with the…
Read More

Helicobacter pylori (H. pylori) infection

William Chey, MD

Helicobacter pylori (H. pylori) infection

Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taking low-dose aspirin or starting therapy with a non-steroidal anti-inflammatory medication, unexplained iron deficiency anemia, and idiopathic thrombocytopenic purpura. This American College of Gastroenterology guideline contains information about the diagnosis and management of patients with suspected or confirmed H. pylori infection. Details regarding the drugs, doses and duration of the recommended and suggested first-line and salvage regimens can be found in the guideline. This EvidenceCare Protocol is based on the American College of Gastroenterology 2017 publication "ACG Clinical Guideline: Treatment of Helicobacter…
Read More

Lower GI Bleeding

Lisa Strate, MD

Lower Gastrointestinal Bleeding

This guideline provides recommendations for the management of patients with acute overt lower gastrointestinal bleeding. Hemodynamic status should be initially assessed with intravascular volume resuscitation started as needed. Risk stratification based on clinical parameters should be performed to help distinguish patients at high- and low-risk of adverse outcomes. Hematochezia associated with hemodynamic instability may be indicative of an upper gastrointestinal (GI) bleeding source and thus warrants an upper endoscopy. In the majority of patients, colonoscopy should be the initial diagnostic procedure and should be performed within 24 h of patient presentation after adequate colon preparation. Endoscopic hemostasis therapy should be provided to patients with high-risk endoscopic stigmata of bleeding including active bleeding, non-bleeding visible vessel, or adherent clot. The endoscopic…
Read More

Neonatal Fever

Nathan Mick, MD

Neonatal Fever

CME: Up to 2 Launch Protocol
The optimal diagnostic workup, empiric treatment, and appropriate disposition of the neonate (infants <90 days old) continues to be challenging for even the most experienced providers. The EvidenceCare Neonatal Fever pathway consolidates the most recent research in this area, and present a protocolized approach. We cover initial assessment and risk stratification of patients in Low Risk and High Risk groups (based on Boston, Rochester, and Philadelphia criteria), decisions about appropriate diagnostic workup, and optimal treatment for your patient.
Read More

Pediatric Advanced Life Support (PALS)

Ghazala Sharief, MD, MBA

Pediatric Advanced Life Support

CME: Up to 2 Launch Protocol
The EvidenceCare Pediatric Advanced Life Support (PALS) pathway offers providers a structured approach to managing pediatric arrhythmias (bradycardia, tachycardia), pediatric resuscitation and post arrest care. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests (OHCA). Recommendations are based off of the 2015 American Heart Association (AHA) guidelines.
Read More

Pediatric Appendicitis

Genevieve Santillanes, MD

Pediatric Advanced Life Support

CME: Up to 4 Launch Protocol
Acute appendicitis is the most common surgical emergency in children and diagnosis is often challenging.A classic presentation is often lacking in children, who may present with vague and nonspecific signs and symptoms that mimic common conditions, such as gastroenteritis. Imaging strategies to aid in the diagnosis of appendicitis include Ultrasound, CT and MRI.Providers must consider if imaging is necessary, and if so, the strengths and limitations of each modality, including potential cancer risk from radiation exposure. The EvidenceCare Pediatric Appendicitis Pathway helps providers risk stratify patients to improve decision making.The Alvarado score, Pediatric Appendicitis Score, Harbor-UCLA Clinical Practice Guideline and Clinical Gestalt are all considered in risk stratification and management of suspected appendicitis.
Read More